3 results match your criteria: "The First Pavlov State Medical University of St. Petersburg[Affiliation]"
Neurol Ther
December 2021
The First Pavlov State Medical University of St. Petersburg, St. Petersburg, Russia.
Introduction: According to the official Russian source, in 2017 only 0.27% of the population of Russia was diagnosed with International Classification of Diseases, tenth revision (ICD-10) F4 category disorders (neurotic, stress-related and somatoform disorders), despite these disorders being among the most prevalent mental disorders worldwide. Here we report the results of a large-scale survey among Russian psychiatrists with the primary objective to assess the proportion of psychiatrists who use the diagnoses of interest (mixed anxiety and depression disorder [MADD], adjustment disorder [AdD], panic disorder [PD], agoraphobia, generalized anxiety disorder [GAD], social phobia, simple phobia, acute stress disorder and posttraumatic stress disorder) and compare results with those of a recent World Psychiatric Association (WPA) and World Health Organization (WHO) survey.
View Article and Find Full Text PDFZh Nevrol Psikhiatr Im S S Korsakova
October 2019
Russian Medical Academy of Continuous Professional Education, Moscow, Russia.
Aim: To assess the efficacy and safety of naproxen in patients with nonspecific low back pain.
Material And Methods: Ninety patients with nonspecific low back pain were enrolled in the study. Patients took 550 mg of naproxen twice a day.
Zh Nevrol Psikhiatr Im S S Korsakova
November 2015
Neurology and Neurosurgery Chair and Clinic of the First Pavlov State Medical University of St. Petersburg of the Ministry of Health of the Russian Federation, Saint Petersburg, Russia.
Aim: Treatment of patients with neurological manifestations of degenerative-dystrophic lesions of the spine must be integrated and optimized from the perspective of pathogenesis. Antiedematous therapy is an important moment that takes into account the development of localized swelling affected the spinal structures. We studied the efficacy of L-lysine aescinat in the treatment of patients with discogenic-venous lumbosacral radiculomyelopathy.
View Article and Find Full Text PDF